Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antitumor fredericamycin derivatives discovered at Biofrontera

Feb. 24, 2004

Novartis presents novel tyrosine kinase inhibitors with utility in leukemia

Feb. 24, 2004

New protein kinase inhibitors for cancer therapy designed at Novartis

Feb. 24, 2004

Phase I trial of PT-523 commences enrollment

Feb. 24, 2004

New tubulysin conjugates for cancer therapy claimed by Morphochem

Feb. 24, 2004

Novartis presents new modulators of Smac/IAP interaction

Feb. 24, 2004

Exelixis files IND for XL-647

Feb. 23, 2004

Promising phase II results found for PCK-3145 in advanced prostate cancer

Feb. 23, 2004

IND filing to study Modrenal for prostate cancer

Feb. 20, 2004

Novel antiproliferative CDK inhibitors prepared and tested by Indian scientists

Feb. 20, 2004

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....